Cargando…

Prospects of plasmapheresis for patients with severe COVID-19

On February 11, 2020, the World Health Organization officially named the infection caused by the new coronavirus “Coronavirus disease 2019” (COVID-19). On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) officially named the infectious matter “severe acute respiratory syn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilmutdinova, Ilmira R., Yakovlev, Maksim Yu., Eremin, Petr S., Fesun, Anatoliy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582395/ https://www.ncbi.nlm.nih.gov/pubmed/33117508 http://dx.doi.org/10.4081/ejtm.2020.9165

Ejemplares similares

Development of nanostructured bioplastic material for wound healing
por: Gilmutdinova, Ilmira R., et al.
Publicado: (2021)

Composites Composed of Hydrophilic and Hydrophobic Polymers, and Hydroxyapatite Nanoparticles: Synthesis, Characterization, and Study of Their Biocompatible Properties
por: Gordienko, Mariia, et al.
Publicado: (2021)

Efficiency of a remote telemedicine rehabilitation program using a special set of physical exercises in patients after COVID-19
por: Gilmutdinova, Ilmira, et al.
Publicado: (2022)

Telemedicine platform COVIDREHAB for remote rehabilitation of patients after COVID-19
por: Gilmutdinova, Ilmira R., et al.
Publicado: (2021)

Impact of plasmapheresis on severe COVID-19
por: Fonseca-González, G., et al.
Publicado: (2023)

The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status
por: Pustovalova, Margarita, et al.
Publicado: (2021)

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
por: Lemarquis, Andri, et al.
Publicado: (2021)

Effectiveness of Plasmapheresis Treatment in the Treatment of Patients with COVID-19 Disease
por: Khodakarim, Nastaran, et al.
Publicado: (2022)

The successful management of an elderly Covid-19 infected patient by plasmapheresis
por: Akkoyunlu, Yasemin, et al.
Publicado: (2020)

Plasmapheresis with corticosteroids and antiviral: a life-saving treatment for severe cases of Covid 19
por: Bagherzade, Mohammad, et al.
Publicado: (2020)

Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection
por: Sadeghi, Alireza, et al.
Publicado: (2023)

Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
por: Balagholi, Sahar, et al.
Publicado: (2020)

Early plasmapheresis in patients with severe hypertriglyceridemia induced acute pancreatitis
por: Nasa, Prashant, et al.
Publicado: (2015)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial
por: Gholinataj jelodar, Mohsen, et al.
Publicado: (2023)

Plasmapheresis: Lifesaving treatment in severe cases of HELLP syndrome
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Severe Hypertriglyceridemia-induced Acute Pancreatitis: Successful Management by Plasmapheresis
por: Ramesh, B. N. R., et al.
Publicado: (2019)

Severe and long-lasting alteration of albumin redox state by plasmapheresis
por: Boss, Kristina, et al.
Publicado: (2022)

Plasmapheresis for systemic vasculitis
por: Fukuoka, Kazuhito, et al.
Publicado: (2022)

Successful treatment of plasmapheresis followed by interferon beta-1a in a child with severe COVID-19
por: Saleh, Rana, et al.
Publicado: (2021)

Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series
por: Dogan, Lerzan, et al.
Publicado: (2020)

Severe Sydenham’s chorea (chorea paralytica) successfully treated with plasmapheresis
por: Miranda, Marcelo, et al.
Publicado: (2015)

Therapeutic Plasmapheresis: A Treatment Modality in Severe Hypertriglyceridemia in Adolescence
por: Afzal, Nayab, et al.
Publicado: (2021)

The Use of Plasmapheresis in a Severe Case of Amiodarone-Induced Thyrotoxicosis
por: Moazezi, Tina, et al.
Publicado: (2023)

A QUANTITATIVE TECHNIQUE FOR PERFORMING PLASMAPHERESIS
por: Melnick, Daniel, et al.
Publicado: (1936)

Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases
por: Hassaniazad, Mehdi, et al.
Publicado: (2021)

Comparison of the Effects of Plasmapheresis, Hemoperfusion, and Convalescent Plasma Therapy on Inflammatory Factors in COVID-19 Patients
por: Akhlaghi, Sedighe Sadadt, et al.
Publicado: (2022)

The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among Covid-19 patients
por: Kelachayeh, Seyede Mahboobeh Raoofi, et al.
Publicado: (2022)

THERAPEUTIC PLASMA EXCHANGE AND DOUBLE FILTRATION PLASMAPHERESIS IN SEVERE NEUROIMMUNE DISORDERS
por: Roman-Filip, Corina, et al.
Publicado: (2019)

Plasmapheresis as an Early Treatment for Severe Hypertriglyceridemia, Acute Pancreatitis, and Diabetic Ketoacidosis
por: Kravetz, Ayesha Monga, et al.
Publicado: (2021)

Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

Severe colchicine poisoning treated successfully with kidney replacement therapy and plasmapheresis: a case report
por: Schaffer, D. H., et al.
Publicado: (2022)

Therapeutic Plasmapheresis: A Revision of Literature
por: Altobelli, Claudia, et al.
Publicado: (2022)

Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors
por: Rosa-Bray, M, et al.
Publicado: (2013)

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study
por: Lin, Youwei, et al.
Publicado: (2022)

THU654 The Use Of Plasmapheresis In A Severe Case Of Amiodarone Induced Thyrotoxicosis
por: Moazezi, Tina, et al.
Publicado: (2023)

Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis
por: Miller, Ann, et al.
Publicado: (2019)

Plasmapheresis in Pediatric Intensive Care Unit
por: Misanovic, Verica, et al.
Publicado: (2016)

SUN-573 Plasmapheresis in Thyroid storm
por: Elmahboubi, Riham
Publicado: (2019)

Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning
por: Shariat, Shiva Samsam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_osn16nmqlk83bithqnrdgrpl7m